Your browser doesn't support javascript.
loading
Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review.
Li, Jia-Jun; Yan, Yan-Yan; Sun, Hong-Mei; Liu, Yun; Su, Chao-Yue; Chen, Hu-Biao; Zhang, Jian-Ye.
Afiliação
  • Li JJ; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Yan YY; Institute of Respiratory and Occupational Diseases, Collaborative Innovation Center for Cancer, Medical College, Shanxi Datong University, Datong, China.
  • Sun HM; School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
  • Liu Y; Infinitus (China) Company Ltd., Jiangmen, China.
  • Su CY; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Chen HB; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Zhang JY; School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Front Pharmacol ; 10: 746, 2019.
Article em En | MEDLINE | ID: mdl-31354475
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Suíça